Kim has taken the VP Business Development role, strengthening the US presence of the German CDMO
Grace Ki, Rentschler Vice President Business Development North America and APAC
German CDMO Rentschler Biopharma SE has announced the hiring of Grace Kim as Vice President Business Development - North America and APAC. A newly created, Kim joins Rentschler growing US-based team.
"We are delighted to have Grace join Rentschler Biopharma," said Federico Pollano, Senior Vice President Business Development. "She is a talented leader with proven experience in successfully growing global CDMO businesses who shares our client-centric approach. Grace will play a key role in expanding our offering of best-in-class services for cell culture projects as well as for new therapeutic modalities. We warmly welcome Grace to our growing US-based team."
Grace Kim is an accomplished business development executive with over 20 years of broad-based experience in the biopharmaceutical industry, holding several global business development positions at companies specialising in process development and cGMP production of recombinant protein therapeutics in both microbial and mammalian expression systems.
Most recently, Kim was Vice President at Northway Biotechpharma, Inc. Before that, she held a senior leadership position with the global contract manufacturing organisation, Samsung Biologics. Kim has a BA from Hamilton College and an MS from The Johns Hopkins University.
Commenting on her appointment, Kim said: "Rentschler Biopharma has a reputation for high quality, dependability and innovation, and I am excited to join the team as it expands its international footprint to the US as well as the Asia Pacific. I look forward to bringing in new strategic partnerships to maximise the utilisation of the Milford site as well as to expand the global business development team, commensurate with growth in business."